Effect of β-Adrenoceptor Antagonist and Angiotensin-converting Enzyme Inhibitor on Hypertension-associated Changes in Adenylyl Cyclase Type V Messenger RNA Expression in Spontaneously Hypertensive Rats-Reference-Cited by-同舟云学术

Effect of β-Adrenoceptor Antagonist and Angiotensin-converting Enzyme Inhibitor on Hypertension-associated Changes in Adenylyl Cyclase Type V Messenger RNA Expression in Spontaneously Hypertensive Rats

Published:2003-05 Issue:5 Volume:41 Page:720-725
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Fujino Takayuki,Hasebe Naoyuki,Kawabe Jun-ichi,Fujita Masaaki,Fukuzawa Jun,Tobise Katsuyuki,Kikuchi Kenjiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference32 articles.

1. The Adenylyl Cyclases as Integrators of Transmembrane Signal Transduction

2. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase

3. Type V, but not Type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity

4. Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs.

5. Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles;Frontiers in Pharmacology;2024-04-03

2. Suppression of tooth movement‐induced sclerostin expression using β‐adrenergic receptor blockers;Oral Diseases;2020-01-28

3. Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging;American Journal of Physiology-Heart and Circulatory Physiology;2013-07-01